fda compounding glp-1 warning letters september 2025 issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading The Anatomy of an FDA
Description
Scientists have identified two plant extracts with potential as GLP-1 agonist weight loss pillsakin to semaglutide injections like Ozempic.

Welcome to our shop 1

Mochi is a direct-to-consumer telemedicine platform offering GLP-1 medications for weight management

The tamper-proof outer carton seal remains unchanged, and rigorous testing confirms full bottle and formula integrity.